DBT: Board Resolution

On September 30, 2021, the Board of Directors of BenTre Pharmaceutical Joint Stock Company approved regulations on information disclosure.

For regulations on information disclosure, please visit Company’s website: http://bepharco.com

HOSE

>   PPC: Notice of EGM (01/10/2021)

>   CRE: Notice of trading of rights by an internal shareholder (01/10/2021)

>   HU3: Record date for seeking shareholders’ approval (01/10/2021)

>   TCO: Board Resolution (01/10/2021)

>   SJD: Asking for the extension of disclosure of semi-annual FS (01/10/2021)

>   SSI: Report on results of trading of rights (01/10/2021)

>   VJC.KIS.M.CA.T.07: Report on the result of covered warrant distribution (01/10/2021)

>   VRE.KIS.M.CA.T.12: Report on the result of covered warrant distribution (01/10/2021)

>   VNM.KIS.M.CA.T.10: Report on the result of covered warrant distribution (01/10/2021)

>   EVS: Change in Establishment and Operation License (01/10/2021)